CSGALNACT1
Aliases:
This biomarker is also known as:- chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1
- CHGN
- chondroitin sulfate N-acetylgalactosaminyltransferase 1
- FLJ11264
- CsGalNAcT-1
- Beta4GalNAcT-1
- beta4GalNAcT
- chondroitin beta1,4 N-acetylgalactosaminyltransferase
- EC 2.4.1.174
- CSGalNAcT-1
- Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1
- ChGn
- CSGALNACT1
- beta4GalNAcT-1
- GALNACT1
Description…
From NCBI Gene: This gene encodes an enzyme that transfers N-acetylglucosamine (GalNAc) to the core tetrasaccharide linker and to elongating chondroitin sulfate chains in proteoglycans. Knockout of the orthologous mouse gene indicates that the protein is necessary for normal cartilage development and aggrecan metabolism. Mutations in this gene are associated with multiple sclerosis progression, and with mild skeletal dysplasia and joint laxity. [provided by RefSeq, Aug 2017]
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Under Review |
|---|---|
| Type: | Gene |
| HGNC Name: | CSGALNACT1 |
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.